Brief: Elixinol Wellness Reconfirms FY24 Revenue Guidance Of A$16M - A$20M

Elixinol Wellness

29/02/2024 01:05

Feb 29 (Reuters) - Elixinol Wellness Ltd  EXL.AX :
    * RECONFIRMS FY24 REVENUE GUIDANCE OF A$16M - A$20M AND
EBITDA
BREAKEVEN BY MID-FY24
    * FY23 REVENUE OF A$8.3M, UP 17%
    * FY ADJUSTED EBITDA LOSS OF A$4.6M VERSUS LOSS OF A$8.5M

Source text for Eikon:  ID:nASX96mgjY 
Further company coverage:  EXL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))